EB

Elena Battistello

Analyst, Novartis Venture Fund at Novartis

Zurich, Zurich

Overview 

Elena Battistello is currently an Analyst at Novartis Venture Fund in Zurich, specializing in cancer immunotherapy and oncology. With a strong background in translational science and precision medicine, she has made significant contributions to the fields of cell therapy and gene editing. Highlights of Elena's career include her extensive experience in oncology research, particularly in single cell sequencing and biomarkers. She has also demonstrated a keen interest in investing in early-stage biotech and pharmaceutical companies focused on therapeutics.

Work Experience 

N

Novartis

  • Analyst, Novartis Venture Fund

    2023 - Current

NY

New York University

  • Postdoctoral Fellow

    2020 - 2023

    Department of Pathology, NYU School of Medicine • Directed research projects aimed at dissecting the epigenetic regulation of T cell exhaustion to improve T-cell therapies efficacy in hematological tumors (Battistello*, Hixon*, Comstock* et al, Molecular Cell, 2023) • Designed a protocol to increase the fitness of CAR-T cells through epigenomic rewiring (patent filed) • Used single-cell transcriptomic and epigenomic tools to dissect the contribution of the tumor microenvironment to CAR-T cell efficacy • Investigated the epigenome of T cell lymphoma clinical samples to identify novel therapeutic targets • Contributed to the design and implementation of clinical studies at NYU Langone Health • Coordinated a team of two technicians and one graduate student • Raised funding through the Swiss National Science Foundation and the Lymphoma Research Foundation ($185,700 total)

Ép

École polytechnique fédérale de Lausanne

  • Postdoctoral Fellow

    2019 - 2019

    • Led research activities targeting therapy resistance in lymphoma • Developed a screening pipeline currently used for drug discovery

  • PhD Student

    2015 - 2019

    Swiss Institute for Experimental Cancer Research, EPFL Department of Computational Biology, University of Lausanne • Directed translational research projects aimed at identifying novel therapeutic targets and immunotherapy approaches in hematological tumors (Dheilly*, Battistello* et al., Cancer Cell, 2020; Battistello et al., Blood, 2018). • Designed a drug discovery platform to target the activity of a specific protease in Diffuse Large B cell Lymphoma • Supervised undergraduate students and served as teaching assistant at Cancer Biology courses

  • Internship

    2015 - 2015

IC

Institut Curie - Research Centre

  • Internship

    2014 - 2014

Ud

Università degli Studi di Padova

  • Internship

    2012 - 2012

Education 

Articles About Elena

Relevant Websites